“Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Review” (2021) Canadian Dermatology Today, 2(s03), pp. 3–8. Available at: https://canadiandermatologytoday.com/article/view/2-s03-devani-prajapati (Accessed: 19 March 2026).